How You Can Help

An Inside Look: 2018 Joint Visiting Committee Symposium
Each year, members of Dana-Farber Cancer Institute’s Presidential Visiting Committees gather for a two-day symposium to hear updates from Institute leaders and physician-scientists on the latest advancements and achievements, and to discuss their ideas for securing more resources for Dana-Farber.

State of the Institute
Laurie H. Glimcher, MD, Dana-Farber’s President & CEO, gives Visiting Committee members an update on the excellent progress in research and care initiatives at the Institute.

A Conversation with Brian Moynihan and Laurie H. Glimcher, MD
Dana-Farber’s President & CEO, Laurie H. Glimcher, MD, sits down for a conversation with Brian Moynihan, Chairman and CEO, Bank of America about the economy, the global financial landscape, healthcare, and the application of new technologies to stay at the forefront of the industry.

Dana-Farber’s Strategic Plan: Launching a New Era
Moderated by Dana-Farber’s President & CEO, Laurie H. Glimcher, MD, Lisa R. Diller, MD, William C. Hahn, MD, PhD, Lesley Solomon, and Eric P. Winer, MD, discuss what it will take to fulfill the goals outlined in the Strategic Plan.

Patient-Focused Drug Development: Engaging Patients to Spark Real Change
Moderated by Dana-Farber’s President & CEO, Laurie H. Glimcher, MD, Giovanni Caforio, MD, George D. Demetri, MD, FACP, FASCO, Katherine A. Janeway, MD, MMSc, and John Maraganore, PhD, discuss how patient-focused drug development can accelerate new lifesaving medicines.